众生药业股价涨6.04%，大成基金旗下1只基金重仓，持有2.81万股浮盈赚取4.41万元

Core Viewpoint - The stock price of Zhongsheng Pharmaceutical has increased by 27.45% over the past four days, reaching 27.57 CNY per share, with a market capitalization of 23.433 billion CNY [1] Company Overview - Zhongsheng Pharmaceutical Co., Ltd. is located in Dongguan, Guangdong Province, established on December 31, 2001, and listed on December 11, 2009. The company focuses on the research, production, and sales of pharmaceuticals [1] - The revenue composition of the company includes: Traditional Chinese Medicine sales 53.03%, chemical drug sales 38.12%, Chinese medicinal materials and decoction pieces sales 6.13%, raw materials and intermediates sales 2.14%, and others 0.58% [1] Fund Holdings - Dachen Fund has a significant holding in Zhongsheng Pharmaceutical, with its Dachen Zhihui Quantitative Multi-Strategy Mixed A Fund (004209) increasing its position by 2,300 shares in the third quarter, totaling 28,100 shares, which accounts for 3.69% of the fund's net value [2] - The fund has generated a floating profit of approximately 44,100 CNY today and 157,400 CNY during the four-day price increase [2] - Dachen Zhihui Quantitative Multi-Strategy Mixed A Fund was established on March 21, 2017, with a current scale of 8.7771 million CNY and a year-to-date return of 28.25% [2]